Cargando…
A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer
B‐cell translocation gene 2 (BTG2) is a tumour suppressor protein known to be downregulated in several types of cancer. In this study, we investigated a potential role for BTG2 in early‐stage non‐small cell lung cancer (NSCLC) survival. We analysed BTG2 methylation data from 1230 early‐stage NSCLC p...
Autores principales: | Shen, Sipeng, Zhang, Ruyang, Guo, Yichen, Loehrer, Elizabeth, Wei, Yongyue, Zhu, Ying, Yuan, Qianyu, Moran, Sebastian, Fleischer, Thomas, Bjaanæs, Maria M., Karlsson, Anna, Planck, Maria, Staaf, Johan, Helland, Åslaug, Esteller, Manel, Su, Li, Chen, Feng, Christiani, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983115/ https://www.ncbi.nlm.nih.gov/pubmed/29656435 http://dx.doi.org/10.1002/1878-0261.12204 |
Ejemplares similares
-
Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC
por: Wei, Yongyue, et al.
Publicado: (2018) -
A trans‐omics assessment of gene–gene interaction in early‐stage NSCLC
por: Chen, Jiajin, et al.
Publicado: (2022) -
Epigenome‐wide three‐way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early‐stage NSCLC
por: Ji, Xinyu, et al.
Publicado: (2022) -
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
por: Dong, Xuesi, et al.
Publicado: (2019) -
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis
por: Zhang, Ruyang, et al.
Publicado: (2019)